Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States

Vaccination and 30-Day Mortality Risk in Children, Adolescents, and Young Adults

(2016) Natalie L. McCarthy et al.   PEDIATRICS

Evaluation of the risk of venous thromboembolism after quadrivalent human papillomavirus vaccination among US females

(2016) W. Katherine Yih et al.   VACCINE

Quadrivalent HPV Vaccination and Risk of Multiple Sclerosis and Other Demyelinating Diseases of the Central Nervous System

(2015) Nikolai Madrid Scheller et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

HPV vaccination crisis in Japan

(2015) Sharon J B Hanley et al.   LANCET

An Overview of Quadrivalent Human Papillomavirus Vaccine Safety

(2015) Michelle Vichnin et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Safety of quadrivalent human papillomavirus vaccine (Gardasil®) in pregnancy: Adverse events among non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006–2013

(2015) Pedro L. Moro et al.   VACCINE

Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus

(2015) Louise S. Brinth et al.   VACCINE

Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine

(2015) Mary Ann Goss et al.   VACCINE

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014

(2015) Sarah Reagan-Steiner et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

HPV Vaccination and Complex Regional Pain Syndrome: Lack of Evidence

(2015) Cindy M. Weinbaum et al.   EBioMedicine

Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Women

(2014) E. M. Kojic et al.   CLINICAL INFECTIOUS DISEASES

Quadrivalent Human Papillomavirus Vaccine and the Risk of Venous Thromboembolism

(2014) Nikolai Madrid Scheller et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescents and young adults

(2014) Vania Giacomet et al.   VACCINE

Immunogenicity and Safety of the Human Papillomavirus 6, 11, 16, 18 Vaccine in HIV-Infected Young Women

(2013) Jessica A. Kahn et al.   CLINICAL INFECTIOUS DISEASES

Safety of Human Papillomavirus Vaccines: A Review

(2013) Kristine K. Macartney et al.   DRUG SAFETY

Comparison of the Immunogenicity and Reactogenicity of Cervarix and Gardasil Human Papillomavirus Vaccines in HIV-Infected Adults: A Randomized, Double-Blind Clinical Trial

(2013) L. Toft et al.   JOURNAL OF INFECTIOUS DISEASES

Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects

(2013) L. Grimaldi-Bensouda et al.   JOURNAL OF INTERNAL MEDICINE

Can HPV immunisation cause ADEM? Two case reports and literature review

(2013) Paolo Pellegrino et al.   Multiple Sclerosis Journal

Reasons for Not Vaccinating Adolescents: National Immunization Survey of Teens, 2008-2010

(2013) P. M. Darden et al.   PEDIATRICS

Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study

(2013) L. Arnheim-Dahlstrom et al.   BMJ-British Medical Journal

Complex regional pain syndrome following immunisation

(2012) Stephanie Richards et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine

(2012) Alexandros Sotiriadis et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Safety of Quadrivalent Human Papillomavirus Vaccine Administered Routinely to Females

(2012) Nicola P. Klein et al.   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young women

(2012) Steven J. Jacobsen et al.   VACCINE

Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome

(2011) Roy Freeman et al.   CLINICAL AUTONOMIC RESEARCH

The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety

(2011) J. Baggs et al.   PEDIATRICS

Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl

(2011) Claudia Della Corte et al.   VACCINE

Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink

(2011) Julianne Gee et al.   VACCINE

An immunological insight into premature ovarian failure (POF)

(2010) Svetlana Dragojević-Dikić et al.   AUTOIMMUNITY REVIEWS

Safety and Immunogenicity of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine in HIV-Infected Children 7 to 12 Years Old

(2010) Myron J Levin et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV‐1–Infected Men

(2010) Timothy Wilkin et al.   JOURNAL OF INFECTIOUS DISEASES

Post-licensure monitoring of HPV vaccine in the United States

(2010) Lauri E. Markowitz et al.   VACCINE

A summary of the post-licensure surveillance initiatives for GARDASIL/SILGARD®

(2010) Paolo Bonanni et al.   VACCINE

Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine

(2009) Barbara A. Slade   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

ACUTE DISSEMINATED ENCEPHALOMYELITIS FOLLOWING VACCINATION AGAINST HUMAN PAPILLOMA VIRUS

(2009) B. Wildemann et al.   NEUROLOGY

Pregnancy and Infant Outcomes in the Clinical Trials of a Human Papillomavirus Type 6/11/16/18 Vaccine

(2009) Suzanne M. Garland et al.   OBSTETRICS AND GYNECOLOGY

Safety of human papillomavirus (HPV) vaccines: A review of the international experience so far

(2009) Theodoros Agorastos et al.   VACCINE

Postural Tachycardia Syndrome

(2008) Blair P. Grubb   CIRCULATION